No retraction, correction or concern found when last checked on Oct 18, 2026.
Brain injury induces specific changes in the caecal microbiota of mice via altered autonomic activity and mucoprotein production
A. Houlden, M. Goldrick, D. Brough and 5 more
Brain, Behavior, and Immunity · 2016 · CC BY
Abstract
Intestinal microbiota are critical for health with changes associated with diverse human diseases. Research suggests that altered intestinal microbiota can profoundly affect brain function. However, whether altering brain function directly affects the microbiota is unknown. Since it is currently unclear how brain injury induces clinical complications such as infections or paralytic ileus, key contributors to prolonged hospitalization and death post-stroke, we tested in mice the hypothesis that brain damage induced changes in the intestinal microbiota. Experimental stroke altered the composition of caecal microbiota, with specific changes in Peptococcaceae and Prevotellaceae correlating with the extent of injury. These effects are mediated by noradrenaline release from the autonomic nervous system with altered caecal mucoprotein production and goblet cell numbers. Traumatic brain injury also caused changes in the gut microbiota, confirming brain injury effects gut microbiota. Changes in intestinal microbiota after brain injury may affect recovery and treatment of patients should appreciate such changes.
Full text
From PubMed Central, U.S. National Library of Medicine, as current on Oct 18, 2026. Paragraph numbers are ours, so an answer can point at one.
Introduction
It is becoming clear that intestinal microbiota play key roles in both host development and in maintaining homeostasis. Intestinal microbiota change with age and are also influenced by environmental factors such as diet, and disease. Recent research highlights the key role of microbial communities in the large intestine in essential immune defence mechanisms and control of inflammatory responses. Impaired regulation of the intestinal microbiota is also known to contribute to diseases of the intestinal tract, and is linked with the development of diverse inflammatory conditions such as sepsis, metabolic disease or cancer. Altered intestinal microbiota have also recently been linked to neuro-behavioural problems such as autism. In fact the effect of microbiota on brain function is profound with microbiota known to influence brain specific activity such as anxiety like behaviour, learning and memory, microglial activity and blood brain barrier integrity. However, much less is known about whether changes in the intestinal microbiota are themselves influenced by central nervous system function. Brain injury caused by stroke is the most common cause of lasting disability worldwide and has a huge socio-economic impact. Beyond the detrimental effects of the initial injury on outcome after acute cerebrovascular events, one of the key causes for death or prolonged hospitalization and impaired recovery of patients is the development of post-stroke infections. In some clinical studies, preventive antibiotic therapy was found beneficial, and recent data indicate that pattern recognition receptors that can recognise microbiota-derived products could contribute to stroke outcome. The enteric nervous system is under central autonomic control and it is believed that the autonomic nervous system contributes to regulation of intestinal immunity and microbiota. We and others have shown that acute brain injury induces diverse autonomic, neuroendocrine and inflammatory changes, which manifest in several organs in the body, leading to immunosuppression and the development of infectious complications. The impact of an acute brain injury on the intestinal microbiota, and whether this is also influenced by neuroendocrine and inflammatory changes as a result of injury, is not known, but could be of importance to the outcome and recovery of the patient.
Here we tested the hypothesis that an acute brain injury induced by experimental stroke or traumatic brain injury would induce specific changes in the gut microbiota. We demonstrate that brain injury profoundly impacts on microbial communities in the caecum and that brain injury is associated with specific changes in microbiota. We propose that these changes are due to increased noradrenaline (NE) release from the autonomic nervous system into the gut. These changes may influence recovery after an acute brain injury.
Mice
Male 10–14 week-old C57BL/6 mice were kept at 22 °C ± 1 °C and 65% humidity with a 12 h light-dark cycle and had free access to food and water. All animal procedures were performed under appropriate project licence authority and adhered to the UK Animals (Scientific Procedures) Act (1986) and the Hungarian Act of Animal Care and Experimentation (1998; XXVIII, Section 243/1998), approved by the Animal Care and Use Committee of the IEM.
Middle cerebral artery occlusion (MCAo)
Transient focal cerebral ischemia was induced as described previously. Briefly, mice were anaesthetised with isoflurane, the common carotid artery was exposed and cerebral ischemia was induced by an intraluminal filament that was advanced along the internal carotid artery, to occlude middle cerebral artery. After 60 min of MCAo, reperfusion was induced for 4 h or 72 h prior to sacrifice. Core body temperature was maintained at 37.0 °C ± 0.5 °C throughout the surgery by a heating blanket (Homeothermic Blanket Control Unit; Harvard Apparatus, Kent, UK) and monitored after recovery. After surgery, animals were returned to their cages and allowed free access to water and food. Neurological deficit in mice was assessed by using Bederson scores (4 point scale of increasing neurological deficit) as described previously. Animals that showed no obvious neurological deficit at 4 h reperfusion after MCAo (score 1 at minimum) have been excluded from the studies pre hoc (n = 1).
Surgical controls
We investigated the effect of surgical manipulation and anaesthesia in the absence of experimental stroke on changes in the intestinal microbiota. To achieve this, two separate experimental conditions were used; the first involved only anaesthesia with no surgical manipulation, the second sham surgery, during which mice underwent all procedures as in the MCAo group, except for occlusion of the MCA with an intraluminal filament.
Traumatic brain injury (TBI)
A closed head model of TBI was performed in mice under isoflurane anaesthesia similarly to what has been described earlier, with slight modifications. After induction of anaesthesia, the skull was exposed by a small, midline longitudinal incision. The head was held in place and a plastic cone was placed on the skull 2 mm lateral of the midline after which a 100 g weight was allowed to fall on the top of the cone from a preestablished height resulting in injury to the left hemisphere, which localised around the affected cerebral cortex (Fig. 7). Mice were allowed to recover and 1 ml of saline was injected subcutaneously for rehydration. We used a relative mild form of TBI resulting in 2 out of 7 mice with substantial neurological deficit as assessed 72 h later. Sham animals were subjected to the same procedure except for head injury.
Pharmacological manipulation of the sympathetic nervous system
A group of mice was injected with the NE reuptake inhibitor atomoxetine (Sigma, 0.1 mg kg−1) and the α2-adrenergic receptor antagonist yohimbine (Sigma, 1 mg kg−1) administered intraperitoneally (0.2 ml/mouse in total), once daily for three subsequent days. Another group of mice received a single intraperitoneal injection of 6-hydroxydopamine (6-OHDA) (0.2 ml, Sigma, 100 mg kg−1) followed by 0.2 ml sterile saline for two subsequent days. Control mice were administered 0.2 ml saline daily for three days. Mice were sacrificed 72 h after the first injection; the caecum was quickly removed and was kept at −80 °C until use.
ELISA
To measure inflammatory changes and neurotransmitter levels in the gut, caecum tissues were washed in sterile saline and homogenised as described previously. Samples were kept at −20 °C until processing. Protein concentrations calculated using a BCA assay (Pierce/Themo Fisher Scientific). Caecum homogenates were measured for granulocyte-colony stimulating factor (G-CSF), RANTES (CCL5), KC (CXCL1), MMP-9, interleukin 6 (IL-6), ICAM-1, VCAM-1 (R & D Systems, UK), adrenaline and noradrenaline (Eagle Biosciences, NH, USA), substance P (R & D Systems, UK), and serotonin (Enzo, UK) according to the manufacturers protocol.
DNA extraction
Genomic DNA was extracted directly from total caecal content (∼250 mg) using the QIAamp DNA Stool Mini Kit (Qiagen) with pathogen protocol.
Community profiling
Bacterial communities were profiled in the mouse caecum using Denaturing Gradient Gel Electrophoresis (DGGE), 454 sequencing (Roche, USA), and Illumina MiSeq (USA). DGGE assessment of the bacterial communities was as follows: PCR amplification of the 16S rRNA gene used universal primers 341F-GC and 518R, and reaction conditions: 5U BioTaq polymerase in 1X buffer (Bioline, UK), 1.5 mM MgCl2, 20 pmol primers, 0.2 mM dNTPs, 5 μg BSA, and 10–50 ng of template DNA in a final volume of 50 μL. The cycle sequence consisted of initial denaturation step of 95 °C 5 min, then 30 cycles of 95 °C 1 min; 55 °C 1 min; 72 °C 1 min, and final extension of 72 °C 10 min. PCR products were purified (QiaGEN Minelute kit) before loading onto a DGGE gel (150 ng/lane). Samples were separated using the D-code system (Bio-Rad, USA) on 10% w/v acrylamide gel with a gradient of 30–70% denaturant at 60 °C for 16 h at 63 V. Gels were stained for 30 min using SYBR Gold (Invitrogen, USA). DGGE Gels were analysed with Phoretix 1D Advanced gel analysis software (Ver. 5.0, Nonlinear Dynamics Ltd.), with binary matrix of band presence/absence of individual bands used for sample comparison.
Pyrosequencing
454 sequencing of the bacterial communities were as follows: The 16S rRNA gene was amplified using the modified 16S primers 66f and 518R (italicised) to include Lib-A (underlined) linker primer sequences required to 454 sequencing and a MID tag to allow sample pooling (Forward primer (Primer A-Key): 5′‐CGTATCGCCTCCCTCGCGCCATCAG(MID)CAGGCCTAACACATGCAAGTC‐3′.
Reverse primer (Primer B-Key): 5′‐CTATGCGCCTTGCCAGCCCGCTCAGATTACCGCGGCTGCTGG‐3′.
Roche multiplex identifiers (MID tags), which are unique “barcode” sequences for each amplified sample were used to allow the pooling of different samples into the same sequencing run. Post sequencing these samples could then be separated on their MIDs back into the individual sample amplified for analysis. MIDs used are detailed in Table S1. All samples were amplified by PCR using the same batch of reagents/buffers to eliminate reagent difference effects, they were also amplified in triplicate to reduce variation in PCR amplicon products. Samples were amplified using the following reaction conditions: 3U Velocity polymerase in 1X buffer (Bioline, UK), 20 pmol primers, 0.2 mM dNTPs, and 10–50 ng of template DNA in a final volume of 50 μL. The cycle parameters used a low cycle number to reduce chimera production, and were as follows: Initial denaturation 95 °C 2 min 30 s, then 18 cycles of 95 °C 10 s; 55 °C 10 s; 72 °C 30 s; with final extension of 72 °C 2 min. Triplicate PCR reactions were pooled, before size selection by gel extraction with the QIAquick gel extraction kit, concentrated by using MinElute PCR Purification Kit (Qiagen), quantified using Qubit dsDNA HS Assay (Life technologies) before pooling of MID tagged products in equimolar amounts in preparation for multiplex barcode pyrosequencing. Roche 454 GS-FLX sequencing was undertaken at the Centre for Genome Research, University of Liverpool. yielding a total of 305,216 reads Sequences were processed with flows trimmed to 400 and processed/cleaned using PyroDist for distance calculation, FCluster for clustering analysis, PyroNoise in mothur based on AmpliconNoiseV1.25.
Ilumina MiSeq
Sequencing of the bacterial communities were undertaken by Centre for Genome Research, University of Liverpool using paired end Ilumina MiSeq, and library prep was as follows: The 16S rRNA gene was amplified using the primers described by producing 254 bp insert, and then nested PCR to add MID tags and including Ilumina adaptor sequences as in the Ilumina Nextera protocol. Samples were amplified using the following reaction conditions: 1X Kapa Mastermix (KapaBiosystems, UK) 10 μM primers, and 5–10 ng of template DNA in 20 μl final volume. Samples were then purified using Ampure beads and resuspend in 10 μl. In the second round PCR 5 ng of template DNA is replaced with 9 μl of purified PCR product. The cycle parameters used a low cycle number to reduce chimera production, and were as follows for both rounds of PCR: Initial denaturation 98 °C 2 min, then 10 cycles of 95 °C 20 s; 65 °C 15 s; 70 °C 30 s; with final extension of 72 °C 5 min. Samples were quantified using Qubit dsDNA HS Assay (Life technologies) before pooling. The sequencing run had on average of 111,536 sequences per sample. Samples were paired and quality trimmed to q20. OTUs were picked at 97% using Open-reference OTU picking strategy (utilizing Greengenes database release Feb-2011; http://greengenes.lbl.gov), and chimera checked with cluster less than 4 sequences removed using scripts in QIIME.
NMDS statistical analysis of all sequencing and the community compositional analysis were undertaken in R statistical package.
All sequencing data has been deposited in the European nucleotide archive and available under accession number PRJEB12833.
[3H]NE uptake and release from the caecum
Mice 72 h after sham surgery or experimental stroke were killed by decapitation and the caecum was rapidly removed. Caecum tissues without caecal content were dissected into 2–3 mm pieces, immediately placed into ice-cold Krebs’ solution (113 mM NaCl, 4.7 mM KCl, 1.2 mM MgSO4, 2.5 mM CaCl2, 25 mM NaHCO3, 1.2 mM KH2PO4, 115 mM glucose, 0.3 mM Na2EDTA, and 0.03 mM ascorbic acid), and continuously gassed with a mixture of 95% O2 and 5% CO2. Caecum slices were washed with 5 ml of Krebs’ solution, and loaded for 45 min with [3H]NE at a concentration of 10 μCi in 1 ml of Krebs’ solution. Slices then were washed three times with 10 ml of ice-cold oxygenated Krebs’ solution and transferred into a four-channel microvolume (100 μl) superperfusion system kept at 37 °C superfused with Krebs’ solution at a rate of 0.5 ml min−1 for 60 min (preperfusion period), and the effluent was discarded. After preperfusion, 19 × 3 min fractions were collected. Electrical stimulation (20 V; 10 Hz; 2 ms; 1200 impulses) was applied during the third (S1) and the thirteenth sample (S2). In some experiments tetrodotoxin (3 μM) was added during the ninth sample (after S1) which was present thereafter in the perfusion fluid to investigate its effect on S2-induced NE release. Then, the caecum slices were removed from the chamber and homogenised in 5 ml of 10% trichloroacetic acid. A 0.5 ml aliquot of the supernatant was added to 2 ml of scintillation mixture (Ultima Gold; Packard, Meridian, CT), and the radioactivity was measured with a Packard 1900 TR liquid scintillation counter. Radioactivity was expressed in terms of disintegration per minute per gram of wet tissue (becquerels per gram). The [3H]NE uptake of slices was defined as the tissue content of radioactivity at the beginning (CB) of the perfusion period. This value was calculated according to the following equation: Σi=1–19 FRi + CE = CB, where FRi is the released radioactivity in the fraction number i, and CE is the tissue content measured at the end of the experiment. The neuronal release of [3H]NE was measured by the integration of the surplus release over baseline in response to electrical stimulation.
Histology
72 h after sham surgery or experimental stroke the caecum was removed and placed immediately into 4% paraformaldehyde (PFA, pH = 7.4) for 24 h prior to paraffin embedding. 5 μm thick sections were mounted onto gelatin-coated slides, deparaffinized and stained with haematoxylin and eosin (H&E), Azan or periodic acid Schiff-alcian blue (PAS), then dehydrated and coverslipped with Depex mounting medium. Mucin-containing cells visualized by PAS staining have been quantified in a blinded manner on 3–3 randomly selected caecum sections in each mouse (n = 4). Catecholaminergic nerve fibers in the caecum were visualized with immunohistochemistry using mouse-anti TH monoclonal antibody (1:100, DiaSorin). The staining was developed with anti-mouse ImmPRESS reagent followed by DAB-Ni peroxidase kit (Vector Laboratories, Burlingame, CA, US), and sections counterstained with cresyl violet.
Statistical analysis
Statistics were undertaken using the R-package, with multivariate analysis was undertaken on these data using the Vegan and Ecodist packages in R. A Non parametric version of multidimensional scaling (NMDS) was used to assess communities using bray-curtis dissimilarities to characterise the difference between communities. The calculated dissimilarity matrix is compressed and modelled in 2 dimensions for NMDS figures in which the physical distances represent the level of similarity between samples, and permutational multivariate analysis of variance using distance matrices (Adonis in Vegan) for comparisons between groups on the distance matrix to give significance values.
Experimental cerebral ischemia
Experimental stroke induced in mice by occlusion of the middle cerebral artery (MCAo) resulted in cerebral ischemia affecting the ipsilateral striatum and the cerebral cortex consistent with our earlier studies (Fig.1A). Sensory-motor functional assessment indicated severe neurological deficit in mice that had undergone 60 min MCAo and 4 or 72 h reperfusion, but no deficit was observed in naïve or sham mice (Fig.1B). We then sought to determine the effects of this injury on the intestinal microbiota. Since experimental stroke induced by MCAo requires acute surgical intervention that includes anaesthesia, we set up additional experimental groups to control for the potential effects of surgical stress and the anaesthetic isoflurane.
Characterisation of microbial communities
To determine the effects of experimental stroke on intestinal microbiota we initially used bacterial community profiling of the caecum by DGGE. Caeca were removed and total genomic DNA was extracted for bacterial community profiling by DGGE. Data were analysed using non-metric multidimensional scaling (NMDS). Fig.1C reveals specific changes in the bacterial communities. No significant change was observed between naïve mice, sham mice, or mice that had undergone MCAo at 4 h post operation using PERMANOVA on the distance matrix created. However, at 72 h post operation there was a shift in microbial populations as result of surgery with an indication of the separation of sham and brain injury animals on their community profile (Fig.1C). The caecal microbial community composition in mice that had experimental stroke and 72 h reperfusion had significantly different communities to naïve mice. Sham operated individuals also had a significantly different microbial community to the naïve population (Fig.1C), indicating that sham surgery alone causes a profound change in caecal microbial community structure. To determine whether differences in caecal microbiota between naïve and operated mice were a result of anaesthesia rather than surgery, we analysed the caecal microbiota in animals that had received anaesthetic alone. Caeca were sampled 72 h post anaesthesia, and from control mice, and community profiled as described above by DGGE (data not shown). NMDS analysis demonstrated that there was no significant difference between mice as a result of the anaesthetic (S1 Figure, adonis: F.Model1,9 = 1.83, pr = 0.081). Therefore the changes identified in the sham mice were mostly a result of the surgery, not the anaesthetic with the small sample (n = 5–6) tested.
To characterise the specific changes occurring as a result of brain injury the composition of the caecal microbiota were determined by 16S rRNA gene amplification followed by pyrosequencing generating an average of 12,335 sequences per sample. Samples demonstrated deep coverage by the levelling of rarefaction curves (S2 Figure) and using goods coverage estimate we found on average 98.99% coverage of operational taxanomic units in samples (OTUs: bacterial species defined at the level of >97% similarity on sequence level of the 16S rRNA gene).
Assessment of the Shannon diversity index of the sequence data showed that there were no significant differences between samples (ANOVA: F2,12 = 0.50, p = 0.62). However, NMDS analysis identified that there was a significant shift in communities as result of stroke or surgery (Fig. 2). To identify any specific bacterial taxa that change as a result of brain injury alone the rarefied sequence data was analysed using proportional data for each taxa calculated using QIIME. ANOVA tests were undertaken for each taxa to identify if treatment had a significant effect on their proportion. To account for any increases in type I errors, the resulting p values table was corrected using the commonly used FDR correction which is commonly used for this type of analysis. We identified that brain injury had a significant effect on the proportion of Peptococcaceae (Fig.3A). TukeyHSD posthoc tests confirmed that as a result of brain injury there was a significant increase in the proportion of Peptococcaceae in comparison to Naïve and Sham mice (p < 0.05). The proportions of Prevotellaceae decreased as a result of either treatment (Fig.3B). TukeyHSD posthoc tests identified that there was a decrease in the proportions of Prevotellaceae as a result of sham in comparison to naïve although not significant (p = 0.08), which declined further as a result of stroke (p ⩽ 0.05). Therefore these data establish that there are specific significant changes to the caecal microbiota as a consequence of experimental stroke that cannot be attributed to the effects of surgery alone.
To assess whether changes as a result of brain injury could occur by chance variation in microbial communities, another experiment was undertaken where 10 naïve mice (n = 5 per cage) were monitored by stool sampling at 0, 28, and 41 days, with the samples subjected to 454 pyrosequencing as detailed above. No significant effect of time or cage housed was found in Shannon bacterial diversity (ANOVA: F2,16 = 0.40, p = 0.676) and (ANOVA: F1,8 = 1.46, p = 0.261) respectively (S3 Figure). NMDS analysis of bacterial composition (S4 Figure), identified a small time dependent change on the bacterial community composition (adonis: F.Model1,28 = 1.71, p = 0.022), which would not be unexpected over 41 days. ANOVA with FDR correction did not identify any taxa that changed with time between samples. This would indicate that microbial communities are very stable in C57BL/6 mice caged in our animal facility, giving us confidence in the brain injury effects identified.
Linking bacterial changes to functional outcome after stroke
To investigate whether brain injury drives autonomic changes in the gut, we assessed levels of key neurotransmitters in the tissue of the caecum. Levels of adrenaline, serotonin, and substance P in the caecum did not change (S4 Figure), but noradrenaline (NE) was significantly increased 72 h after experimental stroke (Fig.4A). Increased NE levels positively correlated with neurological deficit scores (S5 Figure). Relative abundance of Peptococcaceae in the caecum showed a significant positive correlation, whereas abundance of Prevotellaceae showed a significant negative correlation with NE levels (Fig.4B &C) and neurological deficit demonstrated the same correlations (S5 Figure). We have also tested changes in several inflammatory markers in the intestinal tissue, which are known to be associated with alterations in the microbiota. Of these markers RANTES (CCL5) levels showed a positive correlation with the relative abundance of Peptococcaceae in the caecum (S6 Figure).
Brain injury leads to increased release of NE from sympathetic nerves in the caecum and altered mucoprotein production
To investigate how brain injury leads to increased NE production in the caecum, we used a well-established ex vivo approach allowing selective assessment of noradrenergic autonomic regulation in the tissue. Caecum tissue blocks isolated 72 h after sham surgery or experimental stroke were rinsed carefully to eliminate caecal content and were incubated with 3H-NE, allowing uptake and release of 3H-NE upon electric stimulation. Brain injury resulted in a profound increase in autonomic outflow in the caecum indicated by an over threefold increase in 3H-NE tissue uptake and release induced by a 10 Hz stimulation (Fig.5A). To further confirm that brain injury altered autonomic nerve function in the gut and increased NE production/release (Fig.5A) is not due to other cells, such as macrophages that can produce catecholamines, tetrodotoxin was used that selectively blocks the firing of action potentials in nerves by inhibiting voltage-gated sodium channels. Tetrodotoxin completely prevented stimulation-evoked 3H-NE release in the caecum (S7 Figure), indicating that brain injury increases noradrenergic autonomic outflow in the caecum. Histology also confirmed that nerves containing tyrosine hydroxylase (TH, a rate-limiting enzyme of catecholamine biosynthesis) were more abundant in the caecum of mice 72 h after brain injury compared to sham animals (Fig.5B). TH-positive nerve fibers and nerve endings were mostly found in close proximity to mucoprotein-containing cells at the basis of the intestinal epithelium (Fig.5B). To test whether the increased levels of NE were directly affecting the growth of Peptococcaceae and Prevotellaceae in the caecum, caecal contents were obtained from naive mice and cultured anaerobically for 24 h with increased levels of NE. Analysis by Q-PCR showed no correlation between the level of NE and the growth of both bacterial genera (S8 Figure). As such it is our hypothesis that the effects of increased levels of NE on the Peptococcaceae and Prevotellaceae are indirect. It is known that autonomic regulation could indirectly influence the gut microbiota via altered goblet cell function. To test whether brain injury had any effect on mucoprotein production in the caecum the number of cells in the intestinal mucosa containing mixed (both acidic and neutral) mucoproteins and the total number of goblet cells was counted. Both the number of cells containing mixed mucoproteins and the total number of goblet cells were significantly reduced 72 h after brain injury compared to sham mice (Fig. 5C and D). However, no sign of local tissue inflammation, leukocyte infiltration, fibrosis or tissue lesions were seen in the caecum after brain injury as assessed on haematoxylin and eosin (H&E)- and Azan-stained caecum sections (Fig.5C).
Manipulation of the sympathetic nervous system leads to altered mucoprotein production, bacterial community changes, and reduced Prevotellaceae levels in the caecum
To investigate whether changes in sympathetic activity lead to similar alterations in the caecal microbiota in vivo to those seen after ischemic brain injury, two different pharmacological approaches were used 1) A mild increase in systemic sympathetic autonomic tone induced by daily administration of atomoxetine (a NE reuptake inhibitor) and yohimbine (an α2-adrenergic receptor antagonist) or 2) intraperitoneal administration of 6-hydroxydopamine (6-OHDA), which leads to robust NE release followed by depletion of noradrenergic nerve terminals in peripheral tissues. Impact on microbial communities was assessed by sequencing of 16 rRNA gene amplicons using illumina Mi-seq platform resulting in an average of 111,536 sequences per sample with greater than 99.8% coverage of OTUs estimated by good coverage estimates. A rarefied subset of 36,904 sequences was used for all subsequent analysis. The mild increase in systemic sympathetic autonomic tone had no effect on microbial communities in the caecum 72 h later, as identified by 16S rRNA sequencing (Fig. 6A). In contrast, the administration of 6-OHDA resulted in profound changes in the gut microbiota (Fig.6A). The 6-OHDA treatment resulted in differential perturbations of the microbial community causing a significant spread and separation from the control mice when assessed by NMDS (adonis F.model1,12 = 2.90, p = 0.0012). Correlation of bacterial abundances in relation to the NMDS plot identified significant correlations with the Phyla of Firmicutes (R2 = 0.60, p = 0.008) and Bacteroidetes (R2 = 0.58, p = 0.01) and the Bacteroidetes family S24-7 (R2 = 0.78, p = 0.017) (Fig.6A) populations indicating dramatic and differential shifts in the populations. 6-OHDA treatment significantly decreased goblet cell numbers in the caecum, whilst atomoxetine/yohimbine treatment had no effect (Fig.6B). Moreover, 6-OHDA treatment specifically resulted in a 20-fold reduction in Prevotellaceae levels in the caecum, a reduction also observed after experimental stroke (Fig.6C).
Severity of traumatic brain injury correlates with changes in the gut microbiota
We next investigated the impact of alternative models of brain injury on the gut microbiota, and thus subjected mice to mild traumatic brain injury (TBI) using a closed-head injury model (Fig.7A). As with the manipulation of the sympathetic nervous system, communities were assessed using illumina Mi-Seq multiplexed with the run described above. The severity of injury from TBI, as with ischemic brain injury described above, correlated with changes in caecal microbiota (Fig.7B). Bacterial population shifts on NMDS that indicate correlations with neurological deficit as a result of TBI, were identified in Bacteroidetes, the Bacteroidetes family Porphyromonadaceae, Firmicutes and α-Proteobacteria. However in contrast to ischemic brain injury, TBI did not result in changes in Peptococcaceae and Prevotellaceae. Correspondingly, goblet cell numbers after TBI were identical to that seen in control mice (Fig.7C), suggesting that different forms of brain injury shape changes in the gut microbiota through multiple mechanisms.
Discussion
There is an increasing appreciation of the importance of the intestinal microbiota and its contribution to the development and maintenance of physiological systems and homeostasis. Altered intestinal microbiota are linked to neuro-developmental disorders, in addition to a number of immune and inflammatory disease states. While a number of factors are known to influence the intestinal microbiota, such as diet, age, and disease, the effects of brain function per se have not been studied. We show that impairment in brain function, induced by experimental stroke, caused specific and significant changes in the caecal microbiota. These stroke-specific changes occur relatively rapidly, within 72 h, and involve a significant decrease in the levels of Prevotellaceae and an increase in the levels of Peptococcaceae. Prevotellaceae have been shown to be part of the core microbiota of C57Bl/6 mice, as such the consequences of reducing the prevalence of Prevotellaceae is likely to be significant. In humans Prevotellaceae are associated with agrarian diets rich in plant derived material and reductions in the abundance of Prevotellaceae have been detected in the microbiota of autistic children, Crohn’s disease and in children suffering from type 1 diabetes. In contrast, abnormal increases in Prevotellaceae has been found to exacerbate DSS-induced colitis in mice. The significance of the increase in the abundance of Peptococcaceae is less clear since little is known about their role in the intestinal microbiota. Peptococcaceae are relatively minor components of the intestinal microbiota of both mice and humans, and the changes we detect here may be a consequence of the decrease in the levels of Provetellaceae. Nevertheless, since only brain injury, but not surgical stress resulted in changes (over 3-fold) in Peptococcaceae, these changes could be specific indicators of brain injury and their predictive value for functional outcome should be tested in patients with various forms of brain injury. Interestingly, the proinflammatory cytokine, CCL5 (RANTES), which we found to positively correlate with Peptococcaceae levels, has been linked with the development of colitis, therefore the functional role of RANTES in stroke-induced gut microbiota changes will need to be investigated in future studies.
These changes in the caecal microbiota were correlated both with increased levels of NE and noradrenergic innervation as well as the severity of injury. It is well known that NE levels increase following trauma or injury and stroke is known to induce NE in the circulation in line with increased sympathetic activity in both humans and experimental animals. However this is the first evidence for increased NE release and noradrenergic innervation in the caecum following stroke. It is known that NE can be sensed and utilised by bacteria in caecal microbiota and that NE-like molecules can be synthesised by bacteria. However the anatomical and neurochemical evidence data presented here demonstrate the source of the NE in the caecum following stroke would appear to be host derived from sympathetic innervation. It is currently unclear whether brain injury-induced increases in sympathetic outflow in the caecum are due to direct actions of altered central sympatho-motor responses or could also be influenced by changes in parasympathetic activity mediated by the vagus nerve. However these data suggest that specific brain-induced changes in gut NE will influence the microbiome-gut-brain axis and thus affect outcome and behaviour. The effect of early life stress on microbiota has been demonstrated previously, suggesting that stress-induced central or peripheral events could alter the intestinal microbiota.
Gastrointestinal dysfunction occurs frequently in stroke patients in the form of altered intestinal motility, abdominal pain, gastric distension, constipation or ulcers that are linked to altered autonomic activity. Increasing stroke severity is associated with progressive loss of overall autonomic modulation and a progressive shift toward sympathetic dominance in stroke patients. These data therefore suggest that a specific neuronal input or an imbalance in neuro and inflammatory mediators (such as NE reported here for example) in the interstitial intestinal tissue contribute to the signals that regulate the structure of the intestinal microbiota. Although it is known that the growth in pure culture of Prevotella intermedia is inhibited by the presence of stress hormones such as NE, when the mouse microbiota was cultured in vitro in increasing concentrations of NE we did not detect any difference on the levels of Prevotellaceae or Peptococcaceae (S8 Figure). This difference may well reflect that in our experiments we were studying the growth of caecal microbiota consisting of many interacting bacterial species, an approach more likely to reproduce effects inside the caecum rather than pure culture. As such the increase in host-derived NE seen in the experimental stroke may be indirectly affecting the relative growth of Prevotellaceae and Peptococcaceae within the caecal microbiota resulting their changes in abundance. Pharmacological manipulation of the peripheral autonomic nervous system by 6-OHDA strengthened our conclusions that a decrease in Prevotellaceae in the caecum seen after experimental stroke could be due to altered autonomic activity. Intraperitoneally administered 6-OHDA does not cross the BBB and leads to rapid release of NE in the periphery, which has been shown to lead to immediate changes in diverse bacterial species. This is followed by depletion of noradrenergic terminals. We found decreased Prevotellaceae levels 72 h after 6-OHDA administration, which was similar to what seen after experimental stroke. It is currently unclear whether ischemic brain injury leads to increased sympathetic outflow in the caecum via increasing central autonomic tone, or whether cessation of central autonomic control after brain injury is compensated by local increases in NE in the gut. Nevertheless, increased NE release or the dysregulation of autonomic control of the gut after both ischemic brain injury and 6-OHDA would explain similar changes seen in Prevotellaceae.
It is known that autonomic regulation can effect goblet cell function. As such NE could indirectly influence the gut microbiota via altered goblet cell function. Analysis of caecal tissue from stroke animals demonstrated that the number of cells containing mixed mucoproteins and the total number of goblet cells were significantly reduced 72 h after brain injury compared to sham mice (Fig.5C and D). As such changes to the mucosal surface are likely to be generated as a consequence of brain injury. Changes in mucin levels have been linked to gut health and susceptibility to infection, of which bacteria from the family Prevotellaceae have been demonstrated to colonise and utilise mucin. The autonomic nervous system is also known to dampen immune responses although here no sign of local tissue inflammation, leukocyte infiltration, fibrosis or tissue lesions were seen in the caecum after brain injury as assessed on haematoxylin and eosin (H&E)- and Azan-stained caecum sections (Fig.5C). Importantly, 6-OHDA treatment resulted in reduced number of goblet cells in the caecum similarly to what was found after experimental stroke and a decrease in Prevotellaceae was observed in both cases. In contrast, traumatic brain injury did not alter goblet cell numbers or Prevotellaceae levels in the caecum, and caused different community changes.
It should be noted that an important observation of our studies was the effect of sham surgery on the caecal microbiota. We have previously reported the surprisingly significant effects of sham surgery on levels of inflammatory mediators in peripheral tissues and the circulation. In the closed head model of mild traumatic brain injury used here, sham mice only experienced a relatively small manipulation (a small cut on the skin covering the skull) compared to the sham surgery required for the MCAo model of experimental stroke, whilst brain injury and functional deficit were much smaller in the TBI model. This could explain why TBI did not lead to profound changes in goblet cell function and a decrease in Prevotellaceae in the gut, whilst a correlation between increasing neurological deficit and specific changes in microbiota were found. Thus, microbiota changes after TBI could be in part due to a generic stress response that follows tissue injury and also to a different form of brain injury compared to that seen after experimental stroke. Whether the changes we observe on the intestinal microbiota in response to sham surgery and levels of systemic inflammation reported are functionally linked is unknown. However the implications of these observations are far reaching. Firstly, these data indicate that any surgical intervention may profoundly and rapidly influence the caecal microbiota. Such changes could have effects on post-surgical outcome, particularly if the dysbiosis (microbial imbalance on or inside the body) results in changes that favour the growth of potential opportunistic pathogens within the host microbiota. Secondly, the interpretations of experimental observations made from models that utilise surgical intervention may be confounded by surgery-induced changes in the caecal microbiota and inflammatory status. Thus surgical intervention essentially changes the organisms’ baseline and could in effect create a co-morbid state.
In conclusion, our results are the first to show specific changes in the microbiota due to a change in brain function, and also to surgical stress following tissue injury, with the likely involvement of the autonomic nervous system and goblet cells under certain conditions. Identification of the mechanisms involved in this dysbiosis could help us understand how the connectivity between brain function and the intestinal microbiota contributes to health and disease and have important implications in the treatment of patients following traumatic brain injury.
References 59
- 1.
Abt M.C. Commensal bacteria calibrate the activation threshold of innate antiviral immunity. Immunity. 2012;37:158-170.
Not in our library10.1016/j.immuni.2012.04.011
- 2.
Asano Y. Critical role of gut microbiota in the production of biologically active, free catecholamines in the gut lumen of mice. Am. J. Physiol. Gastrointest. Liver Physiol. 2012;303:G1288-95.
Not in our library10.1152/ajpgi.00341.2012
- 3.
Ayres J.S., Trinidad N.J., Vance R.E. Lethal inflammasome activation by a multidrug-resistant pathobiont upon antibiotic disruption of the microbiota. Nat. Med. 2012;18:799-806.
Not in our library10.1038/nm.2729
- 4.
Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B. 1995;57:289-300.
Not in our library
- 5.
Bracci F. Chronic constipation in hemiplegic patients. World J. Gastroenterol. 2007;13:3967-3972.
Not in our library10.3748/wjg.v13.i29.3967
- 6.
Caporaso J.G. Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample. Proc. Natl. Acad. Sci. U.S.A. 2011;108(Suppl.):4516-4522.
Not in our library10.1073/pnas.1000080107
- 7.
Caso J.R. Toll-like receptor 4 is involved in subacute stress-induced neuroinflammation and in the worsening of experimental stroke. Stroke. 2008;39:1314-1320.
Not in our library10.1161/strokeaha.107.498212
- 8.
Cechetto D.F. Autonomic and myocardial changes in middle cerebral artery occlusion: stroke models in the rat. Brain Res. 1989;502:296-305.
Not in our library10.1016/0006-8993(89)90625-2
- 9.
de Jonge W.J. The gut’s little brain in control of intestinal immunity. ISRN Gastroenterol. 2013;2013.
Not in our library10.1155/2013/630159
- 10.
Denes A., Thornton P., Rothwell N.J., Allan S.M. Inflammation and brain injury: acute cerebral ischaemia, peripheral and central inflammation. Brain Behav. Immun. 2010;24:708-723.
Not in our library10.1016/j.bbi.2009.09.010
- 11.
Dénes A., Humphreys N., Lane T.E., Grencis R., Rothwell N. Chronic systemic infection exacerbates ischemic brain damage via a CCL5 (regulated on activation, normal T-cell expressed and secreted)-mediated proinflammatory response in mice. J. Neurosci. 2010;30:10086-10095.
Not in our library10.1523/jneurosci.1227-10.2010
- 12.
- 13.
Denes A. Experimental stroke-induced changes in the bone marrow reveal complex regulation of leukocyte responses. J. Cereb. Blood Flow Metab. 2011;31:1036-1050.
Not in our library10.1038/jcbfm.2010.198
- 14.
Denes A. AIM2 and NLRC4 inflammasomes contribute with ASC to acute brain injury independently of NLRP3. Proc. Natl. Acad. Sci. U.S.A. 2015;112:4050-4055.
Not in our library10.1073/pnas.1419090112
- 15.
Dirnagl U. Stroke-induced immunodepression: experimental evidence and clinical relevance. Stroke. 2007;38:770-773.
Not in our library10.1161/01.str.0000251441.89665.bc
- 16.
Dupont A.W., Dupont H.L. The intestinal microbiota and chronic disorders of the gut. Nat. Rev. Gastroenterol. Hepatol. 2011;8:523-531.
Not in our library10.1038/nrgastro.2011.133
- 17.
Elinav E. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell. 2011;145:745-757.
Not in our library10.1016/j.cell.2011.04.022
- 18.
Flint H.J., Scott K.P., Louis P., Duncan S.H. The role of the gut microbiota in nutrition and health. Nat. Rev. Gastroenterol. Hepatol. 2012;9:577-589.
Not in our library10.1038/nrgastro.2012.156
- 19.
Ganal S.C. Priming of natural killer cells by nonmucosal mononuclear phagocytes requires instructive signals from commensal microbiota. Immunity. 2012;37:171-186.
Not in our library10.1016/j.immuni.2012.05.020
- 20.
Good I.J. The population frequencies of species and the estimation of population parameters. Biometrika. 1953;40:237-264.
Not in our library
- 21.
Goslee S., Urban D. The ecodist package: dissimilarity-based functions for ecological analysis. J. Stat. Softw. 2007;22:1-19.
Not in our library
- 22.
- 23.
Hetze S. Superiority of preventive antibiotic treatment compared with standard treatment of poststroke pneumonia in experimental stroke: a bed to bench approach. J. Cereb. Blood Flow Metab. 2013;33:846-854.
Not in our library10.1038/jcbfm.2013.6
- 24.
Hilz M.J. High NIHSS values predict impairment of cardiovascular autonomic control. Stroke. 2011;42:1528-1533.
Not in our library10.1161/strokeaha.110.607721
- 25.
Hsiao E.Y. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell. 2013;155:1451-1463.
Not in our library10.1016/j.cell.2013.11.024
- 26.
Jentsch H.F.R., März D., Krüger M. The effects of stress hormones on growth of selected periodontitis related bacteria. Anaerobe. 2013;24:49-54.
Not in our library10.1016/j.anaerobe.2013.09.001
- 27.
- 28.
Karavolos M.H., Winzer K., Williams P., Khan C.M.A. Pathogen espionage: multiple bacterial adrenergic sensors eavesdrop on host communication systems. Mol. Microbiol. 2013;87:455-465.
Not in our library10.1111/mmi.12110
- 29.
Kim Y.S., Ho S.B. Intestinal goblet cells and mucins in health and disease: recent insights and progress. Curr. Gastroenterol. Rep. 2010;12:319-330.
Not in our library10.1007/s11894-010-0131-2
- 30.
Korpelainen J.T., Sotaniemi K.A., Myllylä V.V. Autonomic nervous system disorders in stroke. Clin. Auton. Res. 1999;9:325-333.
Not in our library10.1007/bf02318379
- 31.
Le Chatelier E. Richness of human gut microbiome correlates with metabolic markers. Nature. 2013;500:541-546.
Not in our library10.1038/nature12506
- 32.
Luczynski P. Growing up in a bubble: using germ-free animals to assess the influence of the gut microbiota on brain and behaviour. Int. J. Neuropsychopharmacol. 2016.
Not in our library10.1093/ijnp/pyw020
- 33.
Lyte M. Microbial endocrinology and infectious disease in the 21st century. Trends Microbiol. 2004;12:14-20.
Not in our library10.1016/j.tim.2003.11.004
- 34.
Lyte M. Host-microbiota neuroendocrine interactions influencing brain and behavior. Gut Microbes. 2014;5:381-389.
Not in our library10.4161/gmic.28682
- 35.
Lyte M., Bailey M.T. Neuroendocrine-bacterial interactions in a neurotoxin-induced model of trauma. J. Surg. Res. 1997;70:195-201.
Not in our library10.1006/jsre.1997.5130
- 36.
- 37.
Millen J.E., Glauser F.L., Fairman R.P. A comparison of physiological responses to percussive brain trauma in dogs and sheep. J. Neurosurg. 1985;62:587-591.
Not in our library10.3171/jns.1985.62.4.0587
- 38.
Muyzer G., de Waal E.C., Uitterlinden A.G. Profiling of complex microbial populations by denaturing gradient gel electrophoresis analysis of polymerase chain reaction-amplified genes coding for 16S rRNA. Appl. Environ. Microbiol. 1993;59:695-700.
Not in our library10.1128/aem.59.3.695-700.1993
- 39.
Myers M.G., Norris J.W., Hachniski V.C., Sole M.J. Plasma norepinephrine in stroke. Stroke. 1981;12:200-204.
Not in our library10.1161/01.str.12.2.200
- 40.
Nguyen K.D. Alternatively activated macrophages produce catecholamines to sustain adaptive thermogenesis. Nature. 2011;480:104-108.
Not in our library10.1038/nature10653
Cited by papers we hold 15
- The Role of the Gut Microbiota in the Development of Ischemic Stroke · 2022Not checked
- The microbiota-gut-brain axis participates in chronic cerebral hypoperfusion by disrupting the metabolism of short-chain fatty acids · 2022Corrected
- The Influence of Gut Dysbiosis in the Pathogenesis and Management of Ischemic Stroke · 2022No notice
- Gut Bacteria and Neurotransmitters · 2022No notice
- Gut microbiota is causally associated with poststroke cognitive impairment through lipopolysaccharide and butyrate · 2022No notice
- Microbiota in health and diseases · 2022No notice
- Systemic inflammation after stroke: implications for post‐stroke comorbidities · 2022No notice
- The Role of Gut Microbiota in an Ischemic Stroke · 2021No notice
- The surviving sepsis campaign: basic/translational science research priorities · 2020Not checked
- Western diet aggravates neuronal insult in post-traumatic brain injury: Proposed pathways for interplay · 2020Not checked
- Change of intestinal microbiota in cerebral ischemic stroke patients · 2019No notice
- Современные аспекты взаимосвязи функционального состояния автономной нервной системы и клинико-лабораторных показателей гомеостаза организма при повреждениях головного мозга · 2018Not checked
- An insight into intestinal mucosal microbiota disruption after stroke · 2018No notice
- The IMPROVE Guidelines (Ischaemia Models: Procedural Refinements Of in Vivo Experiments) · 2017No notice
- Gut dysbiosis is associated with metabolism and systemic inflammation in patients with ischemic stroke · 2017Corrected
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.